Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study
Received05 February 2015
revised24 April 2015
accepted05 May 2015
20 December 2017 (online)
Background: Utilization of sedative hypnotic drugs for sleeping disorders (SD) raises concerns, particularly among older people. This study compared utilization of conventional psychotropic drugs for SD among patients seeking care from general practitioners (GPs) who strictly prescribe conventional medications (GP-CM), regularly prescribe homeopathy in a mixed practice (GP-Mx), or are certified homeopathic GPs (GP-Ho).
Methods: This was a French population-based cohort study of GPs and their patients consulting for SD, informed through the Pittsburgh sleep quality index (PSQI) questionnaire. Information on psychotropic drugs utilization was obtained from a standardized telephone interview at inclusion, one, three and 12 months.
Results: 346 patients consulting for SD were included. Patients in the GP-Ho group experienced more often severe SD (41.3%) than patients in the GP-CM group (24.3%). Adjusted multivariate analyses showed that patients who chose to be managed by GP-Ho were less likely to use psychotropic drugs over 12 months as opposed to the GP-CM group, with Odds ratio (OR) = 0.25; 95% confidence interval (CI): 0.14 to 0.42. Patients in the GP-Mx group also used less psychotropic drugs but the result was not statistically significant (OR = 0.67; 95% CI: 0.39–1.16). Rates of clinical improvement of the SD did not differ between groups.
Conclusions: Patients with SD who chose to consult GPs certified in homeopathy consumed less psychotropic drugs and had a similar evolution of their condition to patients treated with conventional medical management. This result may translate in a net advantage with reduction of adverse events related to psychotropic drugs.
- 1 Grimaldi-Bensouda L., Begaud B., Lert F.. et al. EPI3-LA-SER Group Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. BMJ Open 2011; 1: e000215.
- 2 Falloon K., Arroll B., Elley C.R., Fernando III A.. The assessment and management of insomnia in primary care. BMJ 2011; 342: d2899.
- 3 Buscemi N., Vandermeer B., Friesen C.. et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007; 22: 1335-1350.
- 4 Glass J., Lanctôt K.L., Herrmann N., Sproule B.A., Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169.
- 5 Frass M., Strassl R.P., Friehs H., Müllner M., Kundi M., Kaye A.D. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012; 12: 45-56.
- 6 Grolleau A., Bégaud B., Verdoux H. Characteristics associated with use of homeopathic drugs for psychiatric symptoms in the general population. Eur Psychiatry 2013; 28: 110-116.
- 7 Cooper K.L., Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 2010; 14: 329-337.
- 8 Sarris J., Byrne G.J. A systematic review of insomnia and complementary medicine. Sleep Med Rev 2011; 15: 99-106.
- 9 Paquin A.M., Zimmerman K., Rudolph J.L. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf 2014; 13: 919-934.
- 10 Backhaus J., Junghanns K., Broocks A., Riemann D., Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 2002; 53: 737-740.
- 11 Grimaldi-Bensouda L., Rossignol M., Aubrun E., El Kerri N., Benichou J., Abenhaim L. PGRx Study Group Agreement between patients' self-report and physicians' prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf 2010; 19: 591-595.
- 12 Grimaldi-Bensouda L., Rossignol M., Aubrun E., Benichou J., Abenhaim L. the GRx Study Group Agreement between patients' self-report and physicians' prescriptions on nonsteroidal anti-inflammatory drugs and other drugs used in musculoskeletal disorders: the international Pharmacoepidemiologic General Research eXtension database. Pharmacoepidemiol Drug Saf 2012; 21: 753-759.
- 13 Grimaldi-Bensouda L., Engel P., Massol J.. et al. EPI3-LA-SER Group Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey. BMJ Open 2012; 2: e001498.
- 14 Schutte-Rodin S., Broch L., Buysse D., Dorsey C., Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4: 487-504.
- 15 Williams-Piehota P.A., Sirois F.M., Bann C.M., Isenberg K.B., Walsh E.G. Agents of change: how do complementary and alternative medicine providers play a role in health behavior change?. Altern Ther Health Med 2011; 17: 22-30.
- 16 Spence D.S., Thompson E.A., Barron S.J. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005; 11: 793-798.
- 17 Güthlin C., Lange O., Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health 2004; 4: 6.
- 18 Van Wassenhoven M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93: 3-11.
- 19 Golden A.G., Qiu D., Roos B.A. Medication assessments by care managers reveal potential safety issues in homebound older adults. Ann Pharmacother 2011; 45: 492-498.